Under the agreement, Evonik will distribute InVitria’s blood-free rHSA portfolio to its biopharma customers
This move positions the U.S.-based consumer healthcare company for a significantly larger role in the rapidly expanding at-home and retail diagnostic testing market
This strategic initiative aims to accelerate proof-of-concept of pipeline assets by streamlining R&D operations
Consolidated revenue from operations stood at Rs. 111.05 crore
AGA affects up to 80 per cent of men across their lifetime and remains one of the most common and most psychologically challenging forms of hair loss
EBITDA was Rs. 2,359.6 crore in the quarter ended September 30, 2025
This collaboration turns kitting into a strategic advantage for sponsors and sites
The modular platform not only targets solid tumors but could also enhance traditional autologous and in vivo T cell therapies
Total income for the period stood at Rs. 7101.28 crore
Subscribe To Our Newsletter & Stay Updated
